Syed Ahmed, MD
Sleep Medicine · Germantown, MDNPI 1144434887
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $57,196 of the $75,431 with a category attached, or 75.8%. 55 manufacturers reported payments, led by AbbVie at 58.5% of the total. Among sleep medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,054 payments — averaging $71.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$44K
- Jazz Pharmaceuticals Inc.$7K
- Biohaven Pharmaceuticals, Inc.$7K
- Biohaven Pharmaceutical Holding Company Ltd.$5K
- Inspire Medical Systems, Inc.$2K
- Lilly USA, LLC$1K
- plus $9K from 49 others
What the payments were for
- Speaking & faculty fees$57,19676%
- Travel & lodging$6951%
- Food & beverage$17,42723%
- Education$1120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$37,035
- QULIPTA$11,625
- NURTEC ODT$11,261
- XYWAV$6,497
- Inspire$1,232
- Exablate$289
- Inspire Upper Airway Stimulation System$235
- INTELLIS ADAPTIVESTIM$163
- ZAVZPRET$146
- RYBELSUS$125
- TYSABRI$122
- Wegovy$122
- Symbravo$122
- VYEPTI$107
- KYPHON Balloon Kyphoplasty$105
- RYTARY$104
How this compares
$75,431 in reported general payments places this provider in the 95th percentile of 41 sleep medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VumerityDiroximel Fumarate | 12 | $80,108 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 24 | $62,640 |
| BotoxOnabotulinumtoxina | 14 | $23,098 |
| RytaryCarbidopa/Levodopa | 14 | $20,284 |
| Nurtec OdtRimegepant Sulfate | 11 | $16,224 |
| Memantine Hcl | 185 | $7,374 |
| Rasagiline Mesylate | 20 | $3,483 |
| Memantine Hcl ErMemantine Hcl | 21 | $3,412 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 102 | $2,251 |
| Levetiracetam | 31 | $1,820 |
| Gabapentin | 95 | $1,587 |
| Propranolol Hcl ErPropranolol Hcl | 35 | $1,563 |
| Primidone | 42 | $1,403 |
| Donepezil Hcl | 89 | $1,342 |
| AmantadineAmantadine Hcl | 18 | $1,313 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BiogenVumerity | $590 | $80,10812 claims |
| AbbVieBotox | $44,115 | $23,09814 claims |
| Amneal Pharmaceuticals LLCRytary | $353 | $20,28414 claims |
| PfizerNurtec Odt | $1,001 | $16,22411 claims |
| Upsher-smith Laboratories LLCTopiramate | $131 | $23711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 41 sleep medicine providers in Maryland.
Other sleep medicine in Germantown
- Asefa MekonnenRockville$28K
- Pamela HowardRockville$14K
- Konrad BakkerFrederick$8K
- Amandeep BawaBaltimore$7K
- Stephanie WappelTowson$4K
- Talar KachechianRockville$4K
- Catherine GriffinBaltimore$3K
- Kanaiyalal PatelGreenbelt$3K
- Nabil AltememiChevy Chase$2K
- Sirisha DevabhaktuniBethesda$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.